Arena Stock Falls On Unusually High Volume (ARNA)

NEW YORK ( TheStreet) -- Arena Pharmaceuticals (Nasdaq: ARNA) is trading at unusually high volume Wednesday with 9.5 million shares changing hands. It is currently at 4.1 times its average daily volume and trading down 42 cents (-12.7%) at $2.84 as of 10:10 a.m. ET.

Arena has a market cap of $232.2 million and is part of the health care sector and drugs industry. Shares are up 74.3% year to date as of the close of trading on Tuesday.

Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.

TheStreet Ratings rates Arena as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. You can view the full Arena Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.
null

If you liked this article you might like

A Stampede of Buying: Cramer's 'Mad Money' Recap (Monday 9/11/17)

Allergan, USG Corp, Arena Pharmaceuticals: 'Mad Money' Lightning Round

These Stocks Have Changed Direction

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says